Tag: Venous stenting

Venovo venous stent returns to US market after 2021 recall

BD recently announced that its Venovo venous stent is back on the U.S. market following a recall last year. In 2019, the company reported that the...

CX 2022: Overtreatment in venous disease: Financial incentives are ‘the elephant...

To combat the “overtreatment problem” in the appropriate care of venous disease, “a concerted, complex, multimodal effort” is required from specialists across disparate parts...

The top 10 most popular Vascular Specialist stories in March

Among the posts catching Vascular Specialist readers' eyes last month were the digital flipbook version of our March print edition, a new study looking...

Database analysis findings ‘matched precisely’ with reported reasons for venous stent...

A recent analysis recalled Venovo and Vici venous stents—initiated last year—characterized “significant differences” between reported device and patient issues, and subsequent interventions for the...

Dedicated vs. non-dedicated: Researchers place venous stenting under the spotlight at...

Venous stenting was a hot topic on the agenda of the recent American Venous Forum (AVF) annual meeting, held this year Feb. 23–26 in Orlando,...

Vascular Specialist–March 2022

In this issue: Dedicated vs. non-dedicated: Researchers place venous stenting under the spotlight at the American Venous Forum (AVF) 2022 annual meeting (p. 1 and...

Venous stents remain durable following pregnancy, researchers find

Iliac vein stents tolerate a gravid uterus well and a possible future pregnancy should not contraindicate their usage in the treatment of pelvic venous...

Risk of venous stent migration ‘rare’ but probably ‘underreported,’ systematic review...

Stent migration following treatment of acute iliofemoral thrombus or venous obstruction is “rare but may be underreported,” with the majority of reported cases being...

Office-based laboratory setting proves ‘safe’ for iliac vein stenting

A retrospective study of 1,223 iliac vein cases performed in three office-based laboratories (OBLs) demonstrated a major complication rate of 0.41%, suggesting these procedures...

VIVID study on Duo venous stent system now fully enrolled, Vesper...

Vesper Medical recently announced the completion of enrollment in its pivotal study—VIVID (Venous stent for the iliofemoral vein investigational clinical trial using the Vesper Duo venous stent...

Philips announces large-scale study outcomes on use of IVUS in peripheral...

Royal Philips has announced the results of a new large-scale real-world analysis of Centers for Medicare & Medicaid Services (CMS) data on the health...

Three-year VIVO results back ‘continued safety and effectiveness’ of Zilver Vena...

Three-year results of the VIVO clinical study support the continued safety and effectiveness of the Zilver Vena venous stent (Cook Medical) in the treatment of symptomatic...

Deep venous stenting presents advantage over ablation in achieving better ulcer...

AMELIA ISLAND, Fla.—“Venous leg ulcers (VLUs) secondary to deep venous stenosis represents a distinct class of patients who require a unique treatment paradigm,” stated...